The Non-PVC IV Bags Market is Projected to Grow to $3.8 Billion by 2030

The healthcare sector is witnessing a steady transformation with the growing preference for safer and more sustainable medical products. Among these, the non-PVC IV bags market is carving out a significant space, driven by advancements in medical technology and increasing awareness about the health risks associated with traditional materials. This overview explores the market's size, key drivers, main players, trends, and segmentation to provide a comprehensive understanding of its long-term growth.

Steady Growth Forecast for the Non-PVC IV Bags Market Size
The non-PVC IV bags market has experienced rapid expansion in recent years. It is projected to increase from $2.28 billion in 2025 to $2.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. This historical growth is largely attributed to rising hospital admissions necessitating IV therapy, the wider adoption of infusion-based drug delivery methods, the growth of chemotherapy treatments, heightened awareness of the health concerns linked to PVC, and the increased usage of sterile fluid delivery systems.

Download a free sample of the non-pvc iv bags market report:
https://thebusinessresearchcompany.com/sample_request?id=15621&type=smp&name=Non-PVC%20IV%20Bags%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR

Outlook and Growth Potential of the Non-PVC IV Bags Market Through 2030
Looking ahead, the market is expected to continue its swift expansion, reaching $3.8 billion by 2030 with an anticipated CAGR of 10.8%. Factors contributing to this upward trajectory include a growing demand for sustainable medical consumables, broader acceptance of preservative-free IV solutions, advancements in targeted drug delivery therapies, increased investments in innovative infusion packaging, and intensified regulatory scrutiny focused on material safety. Key trends shaping this period involve the rising use of PVC-free medical packaging, higher demand for multi-chamber IV bags, increased use of chemically stable polymer materials, expansion of ready-to-use IV solutions, and greater emphasis on drug compatibility.

Leading Organizations in the Non-PVC IV Bags Market
The competitive landscape of the non-PVC IV bags market is shaped by several prominent companies, including Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton dic*kinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, ICU Medical Inc., JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Angiplast Pvt. Ltd., Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH, Sealed Air Corporation, and Kraton Corporation.

View the full non-pvc iv bags market report:
https://thebusinessresearchcompany.com/report/non-pvc-iv-bags-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR

Significant Acquisition Expands Production Network in the Sector
In November 2023, Prange Group, a Germany-based pharmaceutical sales and marketing firm, along with Adragos Pharma, a contract development and manufacturing organization (CDMO) based in Germany, acquired Fresenius Kabi's sterile pharmaceutical production facility. The financial details were not disclosed. This acquisition aims to strengthen their existing production footprint across Europe, North America, and Japan. Fresenius Kabi, a Germany-headquartered manufacturer of non-PVC IV bags, will maintain a long-term supply agreement for products produced at this site, reinforcing its position in the market.

Innovations Enhancing Safety and Sustainability in Non-PVC IV Bags
Top market players are actively developing innovative solutions such as polyolefin shrink films that improve product safety, sustainability, and compatibility with various IV solutions. Polyolefin shrink films are known for their durability, flexibility, and clarity, making them ideal for secure and tamper-resistant packaging in sectors like food, consumer goods, electronics, and pharmaceuticals. Their non-toxic composition and high resistance to punctures enable effective use in diverse temperature environments.

For example, in February 2024, Innovia Films, a UK-based manufacturer and supplier of biaxially-oriented polypropylene film, introduced RayoFloat white APO. This product is a floatable, opaque, low-density polyolefin shrink film designed specifically for light-sensitive products. It features easy label removal during PET recycling, which helps produce high-quality food-grade PET flakes. The film not only offers excellent light-blocking capabilities suitable for dairy, nutritional, and cosmetic items but also supports sustainability goals with up to 20% post-industrial recycled content and compliance with the EU's Packaging and Packaging Waste Regulation (PPWR).

Comprehensive Segmentation of the Non-PVC IV Bags Market
This market is segmented across several key dimensions:
1) By Product Type: Single Chamber and Multi Chamber bags
2) By Material: Ethylene Vinyl Acetate, Polypropylene, Copolyester Ether, and Other Materials
3) By Content: Ready-To-Use Sterile Fluids and Liquid Mixtures
4) By Application: Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Other Applications
5) By End User: Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, and Other End Users

Further breakdown includes:
- Single Chamber bags divided into Standard Single Chamber IV Bags and Flexible Single Chamber IV Bags
- Multi Chamber bags categorized as Dual Chamber IV Bags, Triple Chamber IV Bags, and Multi-Chamber IV Bags with more than three chambers

This segmentation framework highlights the diverse range of products and applications fueling the expansion of the non-PVC IV bags market worldwide.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.